Security key
78667J108
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)
CUSIP: 78667J108
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
- Total 13F shares
- 51,256,195
- Total 13F value
- $370,077,943
- Share change
- -2,161,604
- Put/Call ratio
- 57%
- SEC-reported price per share
- $7.22
- Number of holders
- 171
- Value change
- -$24,510,910
- Number of buys
- 75
- Number of sells
- 81
- Shares outstanding
- 62,650,155
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
171
Top holders
10
SAGE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Sage Therapeutics, Inc. SEC filings
Sage Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 78667J108
Recent filing periods:
Ownership snapshot
Top reported holders of SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VANGUARD GROUP INC
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 10%
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Comparable ownership
Top 5
VANGUARD GROUP INC
10%
FMR LLC
9.3%
RTW INVESTMENTS, LP
8.7%
BlackRock Finance, Inc.
8.3%
Bellevue Group AG
7.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
Company
|
10%
|
$69,681,246
6,416,321 shares
|
— | 30 Jun 2024 |
| FMR LLC |
13F
Company
|
9.3%
|
$63,241,647
5,823,356 shares
|
— | 30 Jun 2024 |
| RTW INVESTMENTS, LP |
13F
Company
|
8.7%
|
$59,519,066
5,480,577 shares
|
— | 30 Jun 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
8.3%
|
$56,641,297
5,215,589 shares
|
— | 30 Jun 2024 |
| Bellevue Group AG |
13F
Company
|
7.1%
|
$48,486,566
4,464,693 shares
|
— | 30 Jun 2024 |
| STATE STREET CORP |
13F
Company
|
4%
|
$26,877,001
2,474,862 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
171
Shares
51,256,195
Rows available
171
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q1 2026 Across Filers
Q1 2026 holders
1
Q3 2024 holders
171
Holder diff
170
| Investor | Q1 2026 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q1 2026 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend